Delpharm Meppel B.V. (primary packaging, secondary packaging, quality control, batch release)
UkraineAll drugs from this manufacturer
-
The drug is indicated for the treatment of anemia in adult patients associated with chronic kidney disease (CKD).
Dosage form: tablets, film-coated
Active substance Dosage roxadustat 20 mg ATC: B03XA05
-
The drug is intended for the treatment of anemia in adult patients associated with chronic kidney disease (CKD).
Dosage form: tablets, film-coated
Active substance Dosage roxadustat 50 mg ATC: B03XA05
-
The drug is indicated for the treatment of anemia in adult patients associated with chronic kidney disease (CKD).
Dosage form: tablets, film-coated
Active substance Dosage roxadustat 70 mg ATC: B03XA05
-
The drug is intended for the treatment of anemia in adult patients associated with chronic kidney disease (CKD).
Dosage form: tablets, film-coated
Active substance Dosage roxadustat 100 mg ATC: B03XA05
-
The drug is indicated for the treatment of anemia in adult patients associated with chronic kidney disease (CKD).
Dosage form: tablets, film-coated
Active substance Dosage roxadustat 150 mg ATC: B03XA05
-
The drug is intended for monotherapy in adult patients with relapsed or refractory acute myeloid leukemia (AML) with a confirmed FLT3 mutation.
Dosage form: tablets, film-coated
Active substance Dosage gilteritinib 40 mg ATC: L01EX13